Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Boye

Showing results (161-170 of 190) with videos related to

Pageof 19
Sort By:
Gene Therapy|April 8, 2016
Reduced retinal transduction and enhanced transgene-directed immunogenicity with intravitreal delivery of rAAV following posterior vitrectomy in dogsR F Boyd, S L Boye, T J Conlon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 9, 2010
Long-term retinal function and structure rescue using capsid mutant AAV8 vector in the rd10 mouse, a model of recessive retinitis pigmentosaJi-jing Pang, Xufeng Dai, Shannon E Boye, et al.
Human Gene Therapy|August 7, 2015
Gene Therapy Fully Restores Vision to the All-Cone Nrl(-/-) Gucy2e(-/-) Mouse Model of Leber Congenital Amaurosis-1Sanford L Boye, James J Peterson, Shreyasi Choudhury, et al.
Iscience|November 14, 2024
Erratum: Safety and improved efficacy signals following gene therapy in childhood blindness caused by <i>GUCY2D</i> mutationsSamuel G Jacobson, Artur V Cideciyan, Allen C Ho, et al.
European Journal of Cardiology|April 1, 1975
Assessment of verapamil in the treatment of angina pectorisF Andreasen, E Boye, E Christoffersen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 25, 2025
Development of an AAV-based gene therapy for the ocular phenotype of Friedreich's ataxiaHeyu Tang, Siddhant Gupte, Emily Xu, et al.
Current Biology : CB|October 25, 2016
NF1 Is a Direct G Protein Effector Essential for Opioid Signaling to Ras in the StriatumKeqiang Xie, Lesley A Colgan, Maria T Dao, et al.
Molecular Therapy. Methods & Clinical Development|September 11, 2023
Dual-AAV vector-mediated expression of <i>MYO7A</i> improves vestibular function in a mouse model of Usher syndrome 1BSamantha C Lau, Mhamed Grati, Kevin Isgrig, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2020
Current Clinical Applications of In Vivo Gene Therapy with AAVsJerry R Mendell, Samiah A Al-Zaidy, Louise R Rodino-Klapac, et al.
Human Gene Therapy|October 26, 2018
Somatic Gene Editing of <i>GUCY2D</i> by AAV-CRISPR/Cas9 Alters Retinal Structure and Function in Mouse and MacaqueK Tyler McCullough, Sanford L Boye, Diego Fajardo, et al.
Pageof 19

Showing results (161-170 of 190) with videos related to

Sort By:
Pageof 19
Gene Therapy|April 8, 2016
Reduced retinal transduction and enhanced transgene-directed immunogenicity with intravitreal delivery of rAAV following posterior vitrectomy in dogsR F Boyd, S L Boye, T J Conlon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 9, 2010
Long-term retinal function and structure rescue using capsid mutant AAV8 vector in the rd10 mouse, a model of recessive retinitis pigmentosaJi-jing Pang, Xufeng Dai, Shannon E Boye, et al.
Human Gene Therapy|August 7, 2015
Gene Therapy Fully Restores Vision to the All-Cone Nrl(-/-) Gucy2e(-/-) Mouse Model of Leber Congenital Amaurosis-1Sanford L Boye, James J Peterson, Shreyasi Choudhury, et al.
Iscience|November 14, 2024
Erratum: Safety and improved efficacy signals following gene therapy in childhood blindness caused by <i>GUCY2D</i> mutationsSamuel G Jacobson, Artur V Cideciyan, Allen C Ho, et al.
European Journal of Cardiology|April 1, 1975
Assessment of verapamil in the treatment of angina pectorisF Andreasen, E Boye, E Christoffersen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 25, 2025
Development of an AAV-based gene therapy for the ocular phenotype of Friedreich's ataxiaHeyu Tang, Siddhant Gupte, Emily Xu, et al.
Current Biology : CB|October 25, 2016
NF1 Is a Direct G Protein Effector Essential for Opioid Signaling to Ras in the StriatumKeqiang Xie, Lesley A Colgan, Maria T Dao, et al.
Molecular Therapy. Methods & Clinical Development|September 11, 2023
Dual-AAV vector-mediated expression of <i>MYO7A</i> improves vestibular function in a mouse model of Usher syndrome 1BSamantha C Lau, Mhamed Grati, Kevin Isgrig, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2020
Current Clinical Applications of In Vivo Gene Therapy with AAVsJerry R Mendell, Samiah A Al-Zaidy, Louise R Rodino-Klapac, et al.
Human Gene Therapy|October 26, 2018
Somatic Gene Editing of <i>GUCY2D</i> by AAV-CRISPR/Cas9 Alters Retinal Structure and Function in Mouse and MacaqueK Tyler McCullough, Sanford L Boye, Diego Fajardo, et al.
Pageof 19